Veracyte SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Other events · Financial statements and exhibits
AI summary, unreviewedVeracyte Q3 2026 Revenue $151.8 Million (+15%) and Non-GAAP EPS $0.51 Beat Consensus; Narrows 2026 Revenue Guidance to $590-$593 Million and Announces $100 Million Buyback
Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits